Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy.
Guerrero-Ferreira R, Taylor NM, Arteni AA, Kumari P, Mona D, Ringler P, Britschgi M, Lauer ME, Makky A, Verasdonck J, Riek R, Melki R, Meier BH, Böckmann A, Bousset L, Stahlberg H. · 2019
Read Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy. by Guerrero-Ferreira R, Taylor NM, Arteni AA, Kumari P, Mona D, Ringler P, Britschgi M, Lauer ME, Makky A, Verasdonck J, Riek R, Melki R, Meier BH, Böckmann A, Bousset L, Stahlberg H. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6957273.txt.
Introduction
Guerrero-Ferreira and co-authors solve two new atomic structures of alpha-synuclein fibrils. Their study appeared in eLife. Clumps rich in this protein mark Parkinson's disease and related disorders inside brain cells. The shape of the fibrils matters for understanding how they form and spread.
Using cryo-electron microscopy, the team resolved two forms, called polymorphs 2a and 2b, at 3.0 and 3.4 angstrom resolution. Both differ radically from earlier structures. Each fibril is 10 nanometres wide, built from two filaments joined by salt bridges between specific amino acids. A region long thought exposed is fully buried by new contacts. A water-shy cleft holds sites of known family mutations. The new maps, the authors say, suggest fresh ideas about fibril growth and stability.
Catalog record
| CREATOR | Guerrero-Ferreira R, Taylor NM, Arteni AA, Kumari P, Mona D, Ringler P, Britschgi M, Lauer ME, Makky A, Verasdonck J, Riek R, Melki R, Meier BH, Böckmann A, Bousset L, Stahlberg H. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 80 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy By Ricardo Guerrero-Ferreira, Nicholas MI Taylor, Ana-Andreea Arteni, Pratibha Kumari, Daniel Mona, Philippe Ringler, Markus Britschgi, Matthias E Lauer, Ali Makky, Joeri Verasdonck, Roland Riek, Ronald Melki Published in: eLife DOI: 10.7554/eLife.48907 ABSTRACT Abstract Intracellular inclusions rich in alpha-synuclein are a hallmark of several neuropathological diseases including Parkinson’s disease (PD). Previously, we reported the structure of alpha-synuclein fibrils (residues 1–121), composed of two protofibrils that are connected via a densely-packed interface formed by residues 50–57 (Guerrero-Ferreira, eLife 218;7:e36402). We here report two new polymorphic atomic structures of alpha-synuclein fibrils termed polymorphs 2a and 2b, at 3.0 Å and 3.4 Å resolution, respectively. These polymorphs show a radically different structure compared to previously reported polymorphs. The new structures have a 10 nm fibril diameter and are composed of two protofilaments which interact via intermolecular salt-bridges between amino acids K45, E57 (polymorph 2a) or E46 (polymorph 2b). The non-amyloid component (NAC) region of alpha-synuclein is fully buried by previously non-described interactions with the N-terminus. A hydrophobic cleft, the location of familial PD mutation sites, and the nature of the protofilament interface now invite to formulate hypotheses about fibril formation, growth and stability. Research organism: E. coli, Human INTRODUCTION Lewy bodies (LB) and Lewy neurites (LN) are neuropathological hallmarks of Parkinson's disease and other Lewy body disorders. These intracellular neuronal features contain a cytoplasmic enrichment of the protein alpha-synuclein (α-Syn), thereby defining these diseases as synucleinopathies (Spillantini et al., 1998a; Spillantini et al., 1997). Apart from this finding in the postmortem brain, the central role of α-Syn in Parkinson’s disease (PD) is highlighted by the fact that certain mutations in the α-Syn gene (SNCA) cause familial forms of PD and other synucleinopathies (Appel-Cresswell et al., 2013; Krüger et al., 1998; Lesage et al., 2013; Pasanen et al., 2014; Polymeropoulos et al., 1997; Zarranz et al., 2004) and that duplication or triplication of the SNCA gene lead to either a sporadic or early-onset PD, respectively, in affected families (Chartier-Harlin et al., 2004; Flagmeier et al., 2016; Fujioka et al., 2014; Ibáñez et al., 2004; Singleton et al., 2003). The 14 kDa protein α-Syn is known to readily form fibrils in vitro (Conway et al., 1998; Hashimoto et al., 1998) and induce α-Syn inclusions when injected in model animals (Mougenot et al., 2012; Peelaerts et al., 2015). Shahmoradian et al. have recently investigated the ultrastructure of LBs, using identification by fluorescence light microscopy and then correlative imaging by electron microscopy (CLEM). They found that a slight minority of analyzed LBs contained filamentous or dense proteinaceous structures, while the vast majority of LBs was primarily composed of membrane fragments (Lewis et al., 2019; Shahmoradian et al., 2019). However, even in those cases, LBs had been identified due to their enrichment of α-Syn (antibody LB509, recognizing residues 115–122 of α-Syn). Moors et al. (2018) recently studied the ultrastructure of LBs by super-resolution light microscopy, revealing an onion-like distribution of different forms of α-Syn in nigral LBs and LNs. Their work suggests LBs to be structured encapsulations of aggregated proteins and lipids. While the structure and building blocks of LBs and the putative involvement of aggregated forms of α-Syn in the formation of LBs or in toxicity towards neurons and glia appear to be more complex than previously thought, it is clear that the protein α-Syn plays a pivotal role in PD, and therefore in LB formation. The conformational state and impact of α-Syn protein may also differ strongly between synucleinopathies. Peng et al. (2018) reported α-Syn preparations from glial cytoplasmic inclusions from multiple system atrophy patients being much more potent in seeding α-Syn aggregation into cell cultures than α-Syn preparations than PD patients. A detailed understanding of the conformational space of structural polymorphs of α-Syn is important to move forward the discovery of diagnostic tools and therapeutics for synucleinopathies, including PD. α-Syn protein consists of 140 amino acids. The N-terminus (residues 1–60) is rich in lysine residues and contains KTK lipid-binding motif repeats associated with vesicle binding (George, 2002; George et al., 1995; Perrin et al., 2000). It is also the region which contains all known SNCA familial PD mutations: A30P (Krüger et al., 1998), E46K (Zarranz et al., 2004), H50Q (Appel-Cresswell et al., 2013; Proukakis et al., 2013), G51D (Lesage et al., 2013), A53E (Pasanen et al., 2014), and A53T (Polymeropoulos et al., 1997). The central region (residues 61–95) is the non-amyloid-ß component (NAC region) (Giasson et al., 2001; Uéda et al., 1993), which is essential for α-Syn aggregation (Li et al., 2002). The related protein ß-synuclein (ß-syn) (Jakes et al., 1994; Stefanis, 2012) lacks a stretch of 12 aminoacid residues within the NAC region (residues 71–82) and is unable to form fibrils. The highly unstructured C-terminus of α-Syn (residues 96–140) can bind calcium and it is populated by negatively charged residues (Li et al., 2007; Post et al., 2018; Vilar et al., 2008). Truncation of this domain may play a role in α-Syn pathology by promoting fibril formation (Crowther et al., 1998; Li et al., 2005; Liu et al., 2005; Wang et al., 2016) and being involved in Lewy body formation (Dufty et al., 2007; Mahul-Mellier et al., 2019; Prasad et al., 2012). Inhibition of C-terminal truncation has also been shown to reduce neurodegeneration in a transgenic mouse model of Multiple System Atrophy (MSA) (Bassil et al., 2016). Amyloid fibrils, even within a single sample, may exhibit heterogeneous conformations, referred to as polymorphism. Different polymorphs can be distinguished based on their diameter, their twist, how many protofilaments form a fibril (Riek, 2017), their behavior under limited proteolysis, their appearance under fiber diffraction (Bousset et al., 2013), or their structure using NMR or cryo- EM (Close et al., 2018; Fändrich et al., 2018; Meier and Böckmann, 2015). The polymorphs can be structurally different at the level of the protofibrils, or in the way the protofilaments assemble. Specifically for α-Syn fibrils, structural heterogeneity has been observed by solid-state NMR (Bousset et al., 2013; Comellas et al., 2012; Comellas et al., 2011; Gath et al., 2012; Gath et al., 2014a; Gath et al., 2014b; Heise et al., 2005; Lv et al., 2012; Verasdonck et al., 2016; Vilar et al., 2008), quenched hydrogen/deuterium (H/D) exchange data (Vilar et al., 2008) and cryo-EM (Guerrero-Ferreira et al., 2018; Li et al., 2018a; Li et al., 2018b). A detailed understanding of the conformational space that structural polymorphs of α-Syn do access is central to not only understand how the same polypeptide chain can fold into different structures, but also to thoroughly characterize materials used for in vitro and in vivo experiments. Our recent work on the structure of recombinant α-Syn(1-121), using cryo-electron microscopy (cryo-EM) (Guerrero-Ferreira et al., 2018) and other investigations on full-length α-Syn (Li et al., 2018a; Li et al., 2018b) revealed α-Syn fibrils in a structure composed of two protofilaments that buried the sites associated with familial PD in the interface region between the two protofilaments. This is here termed α-Syn polymorph 1a. Li et al. (Li et al., 2018a) reported an additional polymorph, here termed α-Syn polymorph 1b, in which the interface between virtually identical protofilaments is different. Previous reports on the structure of α-Syn fibrils